Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

A new conceptual model of pesticide transfers from agricultural land to surface waters with a specific focus on metaldehyde.

Whelan MJ, Ramos A, Villa R, Guymer I, Jefferson B, Rayner M.

Environ Sci Process Impacts. 2020 Feb 11. doi: 10.1039/c9em00492k. [Epub ahead of print]

PMID:
32043103
2.

Correction to: Developing vaccines against epidemic-prone emerging infectious diseases.

Bernasconi V, Kristiansen PA, Whelan M, Román RG, Bettis A, Yimer SA, Gurry C, Andersen SR, Yeskey D, Mandi H, Kumar A, Holst J, Clark C, Cramer JP, Røttingen JA, Hatchett R, Saville M, Norheim G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Feb;63(2):226. doi: 10.1007/s00103-019-03085-8.

PMID:
31915867
3.

Toxicity testing in the 21st century: progress in the past decade and future perspectives.

Krewski D, Andersen ME, Tyshenko MG, Krishnan K, Hartung T, Boekelheide K, Wambaugh JF, Jones D, Whelan M, Thomas R, Yauk C, Barton-Maclaren T, Cote I.

Arch Toxicol. 2020 Jan;94(1):1-58. doi: 10.1007/s00204-019-02613-4. Epub 2019 Dec 17. Review.

PMID:
31848664
4.

Increasing plant availability of legacy phosphorus in calcareous soils using some phosphorus activators.

Teng Z, Zhu J, Shao W, Zhang K, Li M, Whelan MJ.

J Environ Manage. 2020 Feb 15;256:109952. doi: 10.1016/j.jenvman.2019.109952. Epub 2019 Dec 9.

PMID:
31818749
5.

Acquisition of fluoroquinolone resistance leads to increased biofilm formation and pathogenicity in Campylobacter jejuni.

Whelan MVX, Ardill L, Koide K, Nakajima C, Suzuki Y, Simpson JC, Ó Cróinín T.

Sci Rep. 2019 Dec 3;9(1):18216. doi: 10.1038/s41598-019-54620-1.

6.

Developing vaccines against epidemic-prone emerging infectious diseases.

Bernasconi V, Kristiansen PA, Whelan M, Román RG, Bettis A, Yimer SA, Gurry C, Andersen SR, Yeskey D, Mandi H, Kumar A, Holst J, Clark C, Cramer JP, Røttingen JA, Hatchett R, Saville M, Norheim G.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):65-73. doi: 10.1007/s00103-019-03061-2. Review. Erratum in: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Feb;63(2):226.

7.

Mood Monitoring Over One Year for People With Chronic Obstructive Pulmonary Disease Using a Mobile Health System: Retrospective Analysis of a Randomized Controlled Trial.

Whelan ME, Velardo C, Rutter H, Tarassenko L, Farmer AJ.

JMIR Mhealth Uhealth. 2019 Nov 22;7(11):e14946. doi: 10.2196/14946.

8.

Examining the Use of Glucose and Physical Activity Self-Monitoring Technologies in Individuals at Moderate to High Risk of Developing Type 2 Diabetes: Randomized Trial.

Whelan ME, Orme MW, Kingsnorth AP, Sherar LB, Denton FL, Esliger DW.

JMIR Mhealth Uhealth. 2019 Oct 28;7(10):e14195. doi: 10.2196/14195.

9.

Addressing disparities in oral disease in Aboriginal people in Victoria: where to focus preventive programs.

Martin-Kerry JM, Whelan M, Rogers J, Raichur A, Cole D, de Silva AM.

Aust J Prim Health. 2019 Oct 3. doi: 10.1071/PY18100. [Epub ahead of print]

PMID:
31578164
10.

Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.

Paul Friedman K, Gagne M, Loo LH, Karamertzanis P, Netzeva T, Sobanski T, Franzosa JA, Richard AM, Lougee RR, Gissi A, Lee JJ, Angrish M, Dorne JL, Foster S, Raffaele K, Bahadori T, Gwinn MR, Lambert J, Whelan M, Rasenberg M, Barton-Maclaren T, Thomas RS.

Toxicol Sci. 2020 Jan 1;173(1):202-225. doi: 10.1093/toxsci/kfz201.

PMID:
31532525
11.

The influence of inter-particle forces on diffusion at the nanoscale.

Giorgi F, Coglitore D, Curran JM, Gilliland D, Macko P, Whelan M, Worth A, Patterson EA.

Sci Rep. 2019 Sep 3;9(1):12689. doi: 10.1038/s41598-019-48754-5.

12.

Finding synergies for the 3Rs - Repeated Dose Toxicity testing: Report from an EPAA Partners' Forum.

Laroche C, Annys E, Bender H, Botelho D, Botham P, Brendler-Schwaab S, Clayton R, Corvaro M, Dal Negro G, Delannois F, Dent M, Desaintes C, Desprez B, Dhalluin S, Hartmann A, Hoffmann-Doerr S, Hubesch B, Irizar A, Manou I, Müller BP, Nadzialek S, Prieto P, Rasenberg M, Roggeband R, Rowan TG, Schutte K, van de Water B, Westmoreland C, Whelan M, Wilschut A, Zvonimir Z, Cronin MTD.

Regul Toxicol Pharmacol. 2019 Nov;108:104470. doi: 10.1016/j.yrtph.2019.104470. Epub 2019 Aug 31.

13.

Screening for hypertension using emergency department blood pressure measurements can identify patients with undiagnosed hypertension: A systematic review with meta-analysis.

Armitage LC, Whelan ME, Watkinson PJ, Farmer AJ.

J Clin Hypertens (Greenwich). 2019 Sep;21(9):1415-1425. doi: 10.1111/jch.13643. Epub 2019 Aug 6. Review.

14.

Uncertainty and equifinality in environmental modelling of organic pollutants with specific focus on cyclic volatile methyl siloxanes.

Whelan MJ, Kim J, Suganuma N, Mackay D.

Environ Sci Process Impacts. 2019 Jul 17;21(7):1085-1098. doi: 10.1039/c9em00099b.

PMID:
31165835
15.
16.

Carcinogenicity assessment: Addressing the challenges of cancer and chemicals in the environment.

Madia F, Worth A, Whelan M, Corvi R.

Environ Int. 2019 Jul;128:417-429. doi: 10.1016/j.envint.2019.04.067. Epub 2019 May 9. Review.

17.

A high throughput imaging database of toxicological effects of nanomaterials tested on HepaRG cells.

Joossens E, Macko P, Palosaari T, Gerloff K, Ojea-Jiménez I, Gilliland D, Novak J, Fortaner Torrent S, Gineste JM, Römer I, Briffa SM, Valsami-Jones E, Lynch I, Whelan M.

Sci Data. 2019 May 2;6(1):46. doi: 10.1038/s41597-019-0053-2.

18.

The need for integrated public health surveillance to address sexually transmitted and blood-borne syndemics.

Murti M, Wong J, Whelan M, Renda C, Hohenadel K, Macdonald L, Parry D.

Can Commun Dis Rep. 2019 Feb 7;45(2-3):63-66. doi: 10.14745/ccdr.v45i23a03. eCollection 2019 Feb 7.

19.

Influenza outbreaks in Ontario hospitals, 2012-2016.

Murti M, Whelan M, Friedman L, Savic J, Johnstone J, Sider D, Warshawsky B.

Can Commun Dis Rep. 2018 Sep 6;44(9):201-205. doi: 10.14745/ccdr.v44i09a03. eCollection 2018 Sep 6.

20.

Insights into in vitro biokinetics using Virtual Cell Based Assay simulations.

Proença S, Paini A, Joossens E, Sala Benito JV, Berggren E, Worth A, Whelan M, Prieto P.

ALTEX. 2019;36(3):447-461. doi: 10.14573/altex.1812101. Epub 2019 Mar 28.

21.

Clinical Practice Guideline for the Management of Infantile Hemangiomas.

Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, Annam A, Baker CN, Frommelt PC, Hodak A, Pate BM, Pelletier JL, Sandrock D, Weinberg ST, Whelan MA; SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE HEMANGIOMAS.

Pediatrics. 2019 Jan;143(1). pii: e20183475. doi: 10.1542/peds.2018-3475. Review.

22.

Reflections on the progress towards non-animal methods for acute toxicity testing of chemicals.

Prior H, Casey W, Kimber I, Whelan M, Sewell F.

Regul Toxicol Pharmacol. 2019 Mar;102:30-33. doi: 10.1016/j.yrtph.2018.12.008. Epub 2018 Dec 20.

23.

Issues experienced and support provided to adolescents and young adults at the end of active treatment for cancer: A rapid review of the literature.

Lea S, Martins A, Bassett M, Cable M, Doig G, Fern LA, Morgan S, Soanes L, Smith S, Whelan M, Taylor RM.

Eur J Cancer Care (Engl). 2018 Nov;27(6):e12972. doi: 10.1111/ecc.12972. Review.

PMID:
30485604
24.

Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.

Bajis S, Maher L, Treloar C, Hajarizadeh B, Lamoury FMJ, Mowat Y, Schulz M, Marshall AD, Cunningham EB, Cock V, Ezard N, Gorton C, Hayllar J, Smith J, Whelan M, Martinello M, Applegate TL, Dore GJ, Grebely J; LiveRLife Study Group.

Int J Drug Policy. 2018 Nov;61:23-30. doi: 10.1016/j.drugpo.2018.08.011. Epub 2018 Oct 25.

PMID:
30388566
25.

Development of a Climate Change Vulnerability Assessment Using a Public Health Lens to Determine Local Health Vulnerabilities: An Ontario Health Unit Experience.

Levison MM, Butler AJ, Rebellato S, Armstrong B, Whelan M, Gardner C.

Int J Environ Res Public Health. 2018 Oct 12;15(10). pii: E2237. doi: 10.3390/ijerph15102237.

26.

Impact of the Chelsea critical care physical assessment (CPAx) tool on clinical outcomes of surgical and trauma patients in an intensive care unit: An experimental study.

Whelan M, van Aswegen H, Corner E.

S Afr J Physiother. 2018 Aug 23;74(1):450. doi: 10.4102/sajp.v74i1.450. eCollection 2018.

27.

Soil exchange rates of COS and CO18O differ with the diversity of microbial communities and their carbonic anhydrase enzymes.

Meredith LK, Ogée J, Boye K, Singer E, Wingate L, von Sperber C, Sengupta A, Whelan M, Pang E, Keiluweit M, Brüggemann N, Berry JA, Welander PV.

ISME J. 2019 Feb;13(2):290-300. doi: 10.1038/s41396-018-0270-2. Epub 2018 Sep 13.

28.

Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance.

Gouliarmou V, Lostia AM, Coecke S, Bernasconi C, Bessems J, Dorne JL, Ferguson S, Testai E, Remy UG, Brian Houston J, Monshouwer M, Nong A, Pelkonen O, Morath S, Wetmore BA, Worth A, Zanelli U, Zorzoli MC, Whelan M.

Toxicol In Vitro. 2018 Dec;53:233-244. doi: 10.1016/j.tiv.2018.08.004. Epub 2018 Aug 9.

PMID:
30099088
29.

One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspective.

Dal Negro G, Eskes C, Belz S, Bertein C, Chlebus M, Corvaro M, Corvi R, Dhalluin S, Halder M, Harvey J, Hermann M, Hoffmann-Dörr S, Kilian K, Lambrigts D, Laroche C, Louhimies S, Mahony C, Manou I, McNamee P, Prieto P, Reid K, Roggen E, Schutte K, Stirling C, Uhlrich S, Weissenhorn R, Whelan M.

Regul Toxicol Pharmacol. 2018 Nov;99:33-49. doi: 10.1016/j.yrtph.2018.08.002. Epub 2018 Aug 8.

30.

Hepatitis C treatment for difficult to access populations: can telementoring (as distinct from telemedicine) help?

Mohsen W, Chan P, Whelan M, Glass A, Mouton M, Young E, Tran Q, Arora S, Davison S, Lama T, Cobrador C, Levy M.

Intern Med J. 2019 Mar;49(3):351-357. doi: 10.1111/imj.14072. Erratum in: Intern Med J. 2019 May;49(5):683.

PMID:
30091164
31.

Emerging technologies for food and drug safety.

Slikker W Jr, de Souza Lima TA, Archella D, de Silva JB Junior, Barton-Maclaren T, Bo L, Buvinich D, Chaudhry Q, Chuan P, Deluyker H, Domselaar G, Freitas M, Hardy B, Eichler HG, Hugas M, Lee K, Liao CD, Loo LH, Okuda H, Orisakwe OE, Patri A, Sactitono C, Shi L, Silva P, Sistare F, Thakkar S, Tong W, Valdez ML, Whelan M, Zhao-Wong A.

Regul Toxicol Pharmacol. 2018 Oct;98:115-128. doi: 10.1016/j.yrtph.2018.07.013. Epub 2018 Jul 23.

32.

Harvesting the promise of AOPs: An assessment and recommendations.

Carusi A, Davies MR, De Grandis G, Escher BI, Hodges G, Leung KMY, Whelan M, Willett C, Ankley GT.

Sci Total Environ. 2018 Jul 1;628-629:1542-1556. doi: 10.1016/j.scitotenv.2018.02.015. Epub 2018 Feb 22. Review.

33.

Microbial community composition and activity controls phosphorus transformation in rhizosphere soils of the Yeyahu Wetland in Beijing, China.

Teng Z, Zhu Y, Li M, Whelan MJ.

Sci Total Environ. 2018 Jul 1;628-629:1266-1277. doi: 10.1016/j.scitotenv.2018.02.115. Epub 2018 Feb 20.

PMID:
30045548
34.

Using Digital Health Technologies to Understand the Association Between Movement Behaviors and Interstitial Glucose: Exploratory Analysis.

Kingsnorth AP, Whelan ME, Sanders JP, Sherar LB, Esliger DW.

JMIR Mhealth Uhealth. 2018 May 3;6(5):e114. doi: 10.2196/mhealth.9471.

35.

Journeys to Jamaica: A Healthy Dose of Culture, Competence, and Compassion.

Whelan M, Ulrich E, Ginty J, Walsh D.

J Christ Nurs. 2018 Apr/Jun;35(2):E21-E27. doi: 10.1097/CNJ.0000000000000495.

PMID:
29521916
36.

International regulatory requirements for skin sensitization testing.

Daniel AB, Strickland J, Allen D, Casati S, Zuang V, Barroso J, Whelan M, Régimbald-Krnel MJ, Kojima H, Nishikawa A, Park HK, Lee JK, Kim TS, Delgado I, Rios L, Yang Y, Wang G, Kleinstreuer N.

Regul Toxicol Pharmacol. 2018 Jun;95:52-65. doi: 10.1016/j.yrtph.2018.03.003. Epub 2018 Mar 6. Review.

37.

Workshop on acceleration of the validation and regulatory acceptance of alternative methods and implementation of testing strategies.

Piersma AH, Burgdorf T, Louekari K, Desprez B, Taalman R, Landsiedel R, Barroso J, Rogiers V, Eskes C, Oelgeschläger M, Whelan M, Braeuning A, Vinggaard AM, Kienhuis A, van Benthem J, Ezendam J.

Toxicol In Vitro. 2018 Aug;50:62-74. doi: 10.1016/j.tiv.2018.02.018. Epub 2018 Mar 2.

PMID:
29501630
38.

Transition from fractional to classical Stokes-Einstein behaviour in simple fluids.

Coglitore D, Edwardson SP, Macko P, Patterson EA, Whelan M.

R Soc Open Sci. 2017 Dec 13;4(12):170507. doi: 10.1098/rsos.170507. eCollection 2017 Dec.

39.

A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.

Ramirez A, Morris S, Maucourant S, D'Ascanio I, Crescente V, Lu IN, Farinelle S, Muller CP, Whelan M, Rosenberg W.

Vaccine. 2018 Feb 1;36(6):873-880. doi: 10.1016/j.vaccine.2017.12.053. Epub 2018 Jan 3.

PMID:
29306508
40.

Predicted persistence and response times of linear and cyclic volatile methylsiloxanes in global and local environments.

Kim J, Mackay D, Whelan MJ.

Chemosphere. 2018 Mar;195:325-335. doi: 10.1016/j.chemosphere.2017.12.071. Epub 2017 Dec 12.

PMID:
29272801
41.

Metadata Correction: Brain Activation in Response to Personalized Behavioral and Physiological Feedback From Self-Monitoring Technology: Pilot Study.

Whelan ME, Morgan PS, Sherar LB, Kingsnorth AP, Magistro D, Esliger DW.

J Med Internet Res. 2017 Dec 21;19(12):e430. doi: 10.2196/jmir.9426.

42.

Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods.

Casati S, Aschberger K, Barroso J, Casey W, Delgado I, Kim TS, Kleinstreuer N, Kojima H, Lee JK, Lowit A, Park HK, Régimbald-Krnel MJ, Strickland J, Whelan M, Yang Y, Zuang V.

Arch Toxicol. 2018 Feb;92(2):611-617. doi: 10.1007/s00204-017-2097-4. Epub 2017 Nov 10.

43.

Microscopy-based high-throughput assays enable multi-parametric analysis to assess adverse effects of nanomaterials in various cell lines.

Hansjosten I, Rapp J, Reiner L, Vatter R, Fritsch-Decker S, Peravali R, Palosaari T, Joossens E, Gerloff K, Macko P, Whelan M, Gilliland D, Ojea-Jimenez I, Monopoli MP, Rocks L, Garry D, Dawson K, Röttgermann PJF, Murschhauser A, Rädler JO, Tang SVY, Gooden P, Belinga-Desaunay MA, Khan AO, Briffa S, Guggenheim E, Papadiamantis A, Lynch I, Valsami-Jones E, Diabaté S, Weiss C.

Arch Toxicol. 2018 Feb;92(2):633-649. doi: 10.1007/s00204-017-2106-7. Epub 2017 Nov 8.

PMID:
29119250
44.

Brain Activation in Response to Personalized Behavioral and Physiological Feedback From Self-Monitoring Technology: Pilot Study.

Whelan ME, Morgan PS, Sherar LB, Kingsnorth AP, Magistro D, Esliger DW.

J Med Internet Res. 2017 Nov 8;19(11):e384. doi: 10.2196/jmir.8890. Erratum in: http://dx.doi.org/10.2196/jmir.9426. J Med Internet Res. 2017 Dec 21;19(12 ):e430.

45.

Intensive family exposure-based cognitive-behavioral treatment for adolescents with anorexia nervosa.

Iniesta Sepúlveda M, Nadeau JM, Whelan MK, Oiler CM, Ramos A, Riemann BC, Storch EA.

Psicothema. 2017 Nov;29(4):433-439. doi: 10.7334/psicothema2016.372.

PMID:
29048300
46.

CONTRIBUTION OF STAKEHOLDER ENGAGEMENT TO THE IMPACT OF A HEALTH TECHNOLOGY ASSESSMENT: AN IRISH CASE STUDY.

Ryan M, Moran PS, Harrington P, Murphy L, O'Neill M, Whelan M, Teljeur C.

Int J Technol Assess Health Care. 2017 Jan;33(4):424-429. doi: 10.1017/S026646231700085X. Epub 2017 Oct 16.

PMID:
29032786
47.

Sensing interstitial glucose to nudge active lifestyles (SIGNAL): feasibility of combining novel self-monitoring technologies for persuasive behaviour change.

Whelan ME, Kingsnorth AP, Orme MW, Sherar LB, Esliger DW.

BMJ Open. 2017 Oct 8;7(10):e018282. doi: 10.1136/bmjopen-2017-018282.

48.

Elucidating the Behavior of Cyclic Volatile Methylsiloxanes in a Subarctic Freshwater Food Web: A Modeled and Measured Approach.

Krogseth IS, Undeman E, Evenset A, Christensen GN, Whelan MJ, Breivik K, Warner NA.

Environ Sci Technol. 2017 Nov 7;51(21):12489-12497. doi: 10.1021/acs.est.7b03083. Epub 2017 Oct 18.

PMID:
28980809
49.

Phosphorus activators contribute to legacy phosphorus availability in agricultural soils: A review.

Zhu J, Li M, Whelan M.

Sci Total Environ. 2018 Jan 15;612:522-537. doi: 10.1016/j.scitotenv.2017.08.095. Epub 2017 Sep 1.

PMID:
28865270
50.

Music in the NICU: The Role of Nurses in Neuroprotection.

Detmer MR, Whelan ML.

Neonatal Netw. 2017 Jul 1;36(4):213-217. doi: 10.1891/0730-0832.36.4.213.

PMID:
28764824

Supplemental Content

Loading ...
Support Center